Materialise (ADR)
Connects additive-manufacturing software, medical applications, and industrial production services.
Something off on this page? Send us feedback.
Profile
Sells software, patient-specific medical offerings, and industrial manufacturing services for additive manufacturing. Its three segments connect digital design and medical imaging to production.
Links digital design and medical imaging to additive-manufacturing production through Materialise Medical, Materialise Software, and Materialise Manufacturing. Medical includes patient-specific healthcare applications, while Software supplies proprietary tools and Manufacturing provides industrial production services.
Founded as a 3D-printing service business, it developed Mimics to turn CT-scan data into patient-specific anatomical models. Software is transitioning toward cloud and subscription-based delivery while continuing research and development work.
Based in Leuven, Belgium, the group retains a Nasdaq ADS listing and also completed a Euronext listing. Its operating structure centers on the three reportable segments.
Company facts
Categories
Key statistics
Year to date +29.1% · Average volume (30d) 86.5K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Target |
|---|---|---|---|
| Feb 20, 2026 | Cantor Fitzgerald | Target | $10 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026Q2 FY26 | $0.05 | $0.07 | +53.2% | $78.2M | $80.0M | +2.3% | +11.24% |
| May 7, 2026Q1 FY26 | $0.01 | $0.04 | +246.3% | $77.1M | $76.6M | −0.6% | −0.55% |
| Feb 19, 2026Q4 FY25 | $0.07 | $0.12 | +70.3% | $83.1M | $82.4M | −0.8% | −8.12% |
| Oct 28, 2025 | $0.01 | $0.04 | +300.0% | $70.7M | $77.8M | +10.0% | −3.86% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $76.9M | $75.1M | $78.2M | $81.3M | $76.8M | $82.5M | |
| Gross profit | $42.6M | $43.8M | $44.4M | $47.2M | $43.9M | $46.9M | |
| Operating income | $665.1K | $3.2M | $3.0M | $3.6M | $2.4M | $2.4M | |
| Net income | −$617.6K | $230.6K | $2.2M | $7.2M | $2.1M | $3.9M | |
| Diluted EPS | −$0.01 | $0.00 | $0.04 | $0.13 | $0.03 | $0.07 | |
| Gross margin | 55.3% | 58.3% | 56.8% | 58.1% | 57.2% | 56.8% | |
| Operating margin | 0.9% | 4.2% | 3.8% | 4.4% | 3.2% | 2.9% |
Fiscal years (4-quarter sums)FY21 $247.5M · FY22 $268.8M · FY23 $296.8M · FY24 $309.1M · FY25 $311.5M
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $154.9M · Total debt $68.9M · Total assets $483.7M · Shareholders' equity $296.9M
Dividends
No dividends on record.
Ownership
Shares outstanding 58.56M · Float 23.50M · 40.1% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Wilfried Vancraen | 34.02M | 57.60% | 13D | Oct 30, 2025 |
| Disciplined Growth Investors Inc /MN | 1.99M | 3.40% | 13F | Aug 14, 2026 |
| Rock Point Advisors, LLC | 990.9K | 1.69% | 13F | Aug 6, 2026 |
| Archon Capital Management LLC | 766.6K | 1.31% | 13F | Aug 14, 2026 |
| King Luther Capital Management Corp | 628.8K | 1.07% | 13F | Aug 10, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- 3D Systems
Patient-matched surgical planning and 3D-printed medical solutions
- Stratasys
Medical anatomical models and additive-manufacturing systems
- Proto Labs
On-demand 3D printing for prototype and production parts
- Zimmer Biomet
Patient-matched implants designed from CT and 3D reconstruction
- Stryker
Patient-specific surgical planning and 3D-printed CMF implants
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Materialise (ADR) | $7.02 | −0.21% | $411.1M | 26.4 | 42.5 | 1.3 | +4.8% |
| 3D Systems | $3.28 | −0.15% | $535.8M | — | — | 1.4 | −0.3% |
| Stratasys | $7.83 | +1.10% | $671.9M | — | 56.3 | 1.2 | −0.4% |
| Proto Labs | $79.74 | −0.15% | $1.90B | 63.8 | 34.9 | 3.4 | +10.6% |
| Zimmer Biomet | $100.91 | −0.00% | $19.52B | 24.6 | 11.5 | 2.3 | +4.8% |
| Stryker | $334.18 | +1.06% | $126.77B | 34.3 | 20.6 | 4.9 | +9.4% |
| Median | 34.3 | 27.7 | 2.3 | +4.8% |